BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38191555)

  • 1. Developmental basis of SHH medulloblastoma heterogeneity.
    Gold MP; Ong W; Masteller AM; Ghasemi DR; Galindo JA; Park NR; Huynh NC; Donde A; Pister V; Saurez RA; Vladoiu MC; Hwang GH; Eisemann T; Donovan LK; Walker AD; Benetatos J; Dufour C; Garzia L; Segal RA; Wechsler-Reya RJ; Mesirov JP; Korshunov A; Pajtler KW; Pomeroy SL; Ayrault O; Davidson SM; Cotter JA; Taylor MD; Fraenkel E
    Nat Commun; 2024 Jan; 15(1):270. PubMed ID: 38191555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation.
    Tan IL; Wojcinski A; Rallapalli H; Lao Z; Sanghrajka RM; Stephen D; Volkova E; Korshunov A; Remke M; Taylor MD; Turnbull DH; Joyner AL
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3392-3397. PubMed ID: 29531057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell spatial transcriptomic analysis reveals common and divergent features of developing postnatal granule cerebellar cells and medulloblastoma.
    Luo W; Lin GN; Song W; Zhang Y; Lai H; Zhang M; Miao J; Cheng X; Wang Y; Li W; Wei W; Gao WQ; Yang R; Wang J
    BMC Biol; 2021 Jul; 19(1):135. PubMed ID: 34210306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment.
    Tamayo-Orrego L; Charron F
    F1000Res; 2019; 8():. PubMed ID: 31700613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of tumor location on subtypes of medulloblastoma.
    Teo WY; Shen J; Su JM; Yu A; Wang J; Chow WY; Li X; Jones J; Dauser R; Whitehead W; Adesina AM; Chintagumpala M; Man TK; Lau CC
    Pediatr Blood Cancer; 2013 Sep; 60(9):1408-10. PubMed ID: 23512859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedgehog pathway permissive conditions allow generation of immortal cell lines from granule cells derived from cancerous and non-cancerous cerebellum.
    Heil C
    Open Biol; 2019 Jan; 9(1):180145. PubMed ID: 30958113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional repressor REST drives lineage stage-specific chromatin compaction at
    Dobson THW; Tao RH; Swaminathan J; Maegawa S; Shaik S; Bravo-Alegria J; Sharma A; Kennis B; Yang Y; Callegari K; Haltom AR; Taylor P; Kogiso M; Qi L; Khatua S; Goldman S; Lulla RR; Fangusaro J; MacDonald TJ; Li XN; Hawkins C; Rajaram V; Gopalakrishnan V
    Sci Signal; 2019 Jan; 12(565):. PubMed ID: 30670636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma.
    Lee SJ; Lindsey S; Graves B; Yoo S; Olson JM; Langhans SA
    PLoS One; 2013; 8(8):e71455. PubMed ID: 23951168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
    Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
    Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity.
    Smit MJ; Martini TEI; Armandari I; Bočkaj I; Zomerman WW; de Camargo Magalhães ES; Siragna Z; Meeuwsen TGJ; Scherpen FJG; Schoots MH; Ritsema M; den Dunnen WFA; Hoving EW; Paridaen JTML; de Haan G; Guryev V; Bruggeman SWM
    J Cell Sci; 2022 Jun; 135(11):. PubMed ID: 35535520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
    Leskoske KL; Garcia-Mansfield K; Sharma R; Krishnan A; Rusert JM; Mesirov JP; Wechsler-Reya RJ; Pirrotte P
    J Proteome Res; 2022 Sep; 21(9):2124-2136. PubMed ID: 35977718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.
    Menyhárt O; Győrffy B
    Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
    PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.
    Kutscher LM; Okonechnikov K; Batora NV; Clark J; Silva PBG; Vouri M; van Rijn S; Sieber L; Statz B; Gearhart MD; Shiraishi R; Mack N; Orr BA; Korshunov A; Gudenas BL; Smith KS; Mercier AL; Ayrault O; Hoshino M; Kool M; von Hoff K; Graf N; Fleischhack G; Bardwell VJ; Pfister SM; Northcott PA; Kawauchi D
    Genes Dev; 2020 Sep; 34(17-18):1161-1176. PubMed ID: 32820036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling.
    Chen L; Li Y; Song Z; Xue S; Liu F; Chang X; Wu Y; Duan X; Wu H
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202821119. PubMed ID: 35969743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
    Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
    Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.
    Ocasio JK; Babcock B; Malawsky D; Weir SJ; Loo L; Simon JM; Zylka MJ; Hwang D; Dismuke T; Sokolsky M; Rosen EP; Vibhakar R; Zhang J; Saulnier O; Vladoiu M; El-Hamamy I; Stein LD; Taylor MD; Smith KS; Northcott PA; Colaneri A; Wilhelmsen K; Gershon TR
    Nat Commun; 2019 Dec; 10(1):5829. PubMed ID: 31863004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model.
    Niesen J; Ohli J; Sedlacik J; Dührsen L; Hellwig M; Spohn M; Holsten T; Schüller U
    Cancer Lett; 2020 May; 477():10-18. PubMed ID: 32112900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNF220 is required for cerebellum development and regulates medulloblastoma progression through epigenetic modulation of Shh signaling.
    Ma P; An T; Zhu L; Zhang L; Wang H; Ren B; Sun B; Zhou X; Li Y; Mao B
    Development; 2020 Jun; 147(21):. PubMed ID: 32376680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma.
    Merk DJ; Ohli J; Merk ND; Thatikonda V; Morrissy S; Schoof M; Schmid SN; Harrison L; Filser S; Ahlfeld J; Erkek S; Raithatha K; Andreska T; Weißhaar M; Launspach M; Neumann JE; Shakarami M; Plenker D; Marra MA; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJM; Lutz B; Ertl-Wagner B; Rossi A; Wagener R; Siebert R; Jung A; Eberhart CG; Lach B; Sendtner M; Pfister SM; Taylor MD; Chavez L; Kool M; Schüller U
    Dev Cell; 2018 Mar; 44(6):709-724.e6. PubMed ID: 29551561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.